We welcome new additions to our portfolio – Stage I
The INCATE Selection Committee selected the new 6 ventures [...]
“Navigating the Landscape: Strategies for Early-Stage Developmental Funding” at AMR World Congress
The 10th edition of the AMR World Congress, set to [...]
Iringó Demeter joins INCATE Management
August 12th, 2024 - INCATE, the INCubator for Antibacterial [...]
INCATE receives Lighthouse Award 2024 from Swiss National Science Foundation
Photos: NCCR AntiResist June 28th 2024 – INCATE, the INCubator [...]
New additions to our portfolio – Stage I March 2024
Just two days before the 8th AMR Conference opened its [...]
The busy and insightful AMR week in Basel
The AMR conference has established itself as the premier European [...]
Highlights of the workshop “Phages: what’s new and what’s next?”
Basel was definitely the place to be in the week [...]
Kick-off the busy week: Selection Committee Meeting
Basel is the place to be this week, and believe [...]
Xiretsa wins Stage II Funding: boosting a new class of Antibiotics
February 2024 – Xiretsa, Inc is the second selected venture [...]
SPRIND calls for unconventional innovations to fight AMR
Do you have an outstanding antimicrobial resistance (AMR) innovation that [...]
